[Acromegaly as a differential diagnosis of hyperphosphatemia].

Acromegaly is characterized by hypersecretion of growth hormone (GH) caused by a pituitary adenoma in 99% of cases. Increased serum phosphate is a rare finding in this pathology. This hyperphosphatemia results from increased phosphate reabsorption in the proximal renal tubule via sodium-phosphate cotransporter type IIa: an effect mediated by insulin-like factor 1 (IGF-1) consequent to excess GH. We present the clinical case of a 66-year-old woman with persistent hyperphosphatemia 4.8 ng/dl (VN: 2.5-4.5) with elevated tubular phosphorus reabsorption (TPR) 95% (VN: 85-94) with subtle features of acromegaly. Acromegaly was diagnosed by IGF1 measurements and oral glucose tolerance test with GH measurement (OGTT/GH). In search of the source of GH hypersecretion, a pituitary MRI was requested, and the pituitary microadenoma was evident only in the third year of follow-up. Achieving remission of the disease (IGF-1 in normal range) after transsphenoidal endoscopic surgery and observing normalization of previous hyperphosphatemia. No evidence of recurrence was found in the 18 years of follow-up. In cases of hyperphosphatemia to review the signs and symptoms of acromegaly to diagnose and treat in early stages, when the probability of remission is high.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2025-01-01
Primary Topic
Parathyroid Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

[Acromegaly as a differential diagnosis of hyperphosphatemia].

Mariela Glerean, Mirena Buttazzoni, Mariela Varsavsky
PubMed
Parathyroid Disorders and Treatments
article

[Acromegaly as a differential diagnosis of hyperphosphatemia].

Mariela Glerean, Mirena Buttazzoni, Mariela Varsavsky
article en

Abstract

Acromegaly is characterized by hypersecretion of growth hormone (GH) caused by a pituitary adenoma in 99% of cases. Increased serum phosphate is a rare finding in this pathology. This hyperphosphatemia results from increased phosphate reabsorption in the proximal renal tubule via sodium-phosphate cotransporter type IIa: an effect mediated by insulin-like factor 1 (IGF-1) consequent to excess GH. We present the clinical case of a 66-year-old woman with persistent hyperphosphatemia 4.8 ng/dl (VN: 2.5-4.5) with elevated tubular phosphorus reabsorption (TPR) 95% (VN: 85-94) with subtle features of acromegaly. Acromegaly was diagnosed by IGF1 measurements and oral glucose tolerance test with GH measurement (OGTT/GH). In search of the source of GH hypersecretion, a pituitary MRI was requested, and the pituitary microadenoma was evident only in the third year of follow-up. Achieving remission of the disease (IGF-1 in normal range) after transsphenoidal endoscopic surgery and observing normalization of previous hyperphosphatemia. No evidence of recurrence was found in the 18 years of follow-up. In cases of hyperphosphatemia to review the signs and symptoms of acromegaly to diagnose and treat in early stages, when the probability of remission is high.

PubMedVol. 85(2)
Hospital Italiano de Buenos Aires (AR)
Openalex Percentile: Top 91%
Parathyroid Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

[Acromegaly as a differential diagnosis of hyperphosphatemia]. — Mariela Glerean, Mirena Buttazzoni, et al. · PubMed (2025) | TGRS Research Map | TGRS